Drug Evaluation Committee The 139th Annual Meeting of the Drug Evaluation Committee Looking Back on the New Coronavirus" - Toward Sharing Best Practices and Resolving Domestic Issues
Nov 02, 2021
- 0_Program (425KB)
- 1_Development of Comunity (693KB)
- 2_Development to Approval of Baricitinib for the Treatment of SARS-CoV-2 Pneumonia (1.2MB)
- 3_New Coronavirus and Ivermectin (2.0MB)
- 4_Future of the pharmaceutical industry read from the pandemic (1.9MB)
- 5_COVID-19 Regulatory Science in Emergency Situations (5.0MB)